Abstract
Two applications claim novel bicyclic azole carboxamide derivatives as histamine H4 receptor antagonists. Benzoimidazole, benzoxazole, indoles, benzothiazole, furopyrroles and thienopyrrole carboxamide derivatives, mostly as piperazine amides, are claimed. These amides are claimed to be useful in the treatment of diseases such as asthma and allergic rhinitis.